72 related articles for article (PubMed ID: 24950407)
21. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of Bcl-xL recognition by a BH3-mimetic α/β-peptide generated by sequence-based design.
Lee EF; Smith BJ; Horne WS; Mayer KN; Evangelista M; Colman PM; Gellman SH; Fairlie WD
Chembiochem; 2011 Sep; 12(13):2025-32. PubMed ID: 21744457
[TBL] [Abstract][Full Text] [Related]
23. The structural basis of Bcl-2 mediated cell death regulation in hydra.
Banjara S; D Sa J; Hinds MG; Kvansakul M
Biochem J; 2020 Sep; 477(17):3287-3297. PubMed ID: 32776134
[TBL] [Abstract][Full Text] [Related]
24. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
25. NMR determination that an extended BH3 motif of pro-apoptotic BID is specifically bound to BCL-XL.
Ji H; Shekhtman A; Ghose R; McDonnell JM; Cowburn D
Magn Reson Chem; 2006 Jul; 44 Spec No(Spec No):S101-7. PubMed ID: 16826547
[TBL] [Abstract][Full Text] [Related]
26. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
27. Screening efficient BH3-mimetics to hBcl-B by means of peptidodynmimetic method.
Sivakumar D; Gorai B; Sivaraman T
Mol Biosyst; 2013 Apr; 9(4):700-12. PubMed ID: 23385522
[TBL] [Abstract][Full Text] [Related]
28. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
[TBL] [Abstract][Full Text] [Related]
29. Expression and spectroscopic analysis of a mutant hepatitis B virus onco-protein HBx without cysteine residues.
Rui E; Moura PR; Gonçalves Kde A; Kobarg J
J Virol Methods; 2005 Jun; 126(1-2):65-74. PubMed ID: 15847920
[TBL] [Abstract][Full Text] [Related]
30. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
Muchmore SW; Sattler M; Liang H; Meadows RP; Harlan JE; Yoon HS; Nettesheim D; Chang BS; Thompson CB; Wong SL; Ng SL; Fesik SW
Nature; 1996 May; 381(6580):335-41. PubMed ID: 8692274
[TBL] [Abstract][Full Text] [Related]
31. Biophysical basis of the promiscuous binding of B-cell lymphoma protein 2 apoptotic repressor to BH3 ligands.
Bhat V; Olenick MB; Schuchardt BJ; Mikles DC; McDonald CB; Farooq A
J Mol Recognit; 2013 Oct; 26(10):501-13. PubMed ID: 23996493
[TBL] [Abstract][Full Text] [Related]
32. Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Arch Biochem Biophys; 2012 Dec; 528(2):156-62. PubMed ID: 22982405
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.
Leupin O; Bontron S; Schaeffer C; Strubin M
J Virol; 2005 Apr; 79(7):4238-45. PubMed ID: 15767425
[TBL] [Abstract][Full Text] [Related]
34. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
35. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis.
Han J; Modha D; White E
Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701
[TBL] [Abstract][Full Text] [Related]
36. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
Day CL; Smits C; Fan FC; Lee EF; Fairlie WD; Hinds MG
J Mol Biol; 2008 Jul; 380(5):958-71. PubMed ID: 18589438
[TBL] [Abstract][Full Text] [Related]
37. Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins.
Lama D; Sankararamakrishnan R
Biochemistry; 2010 Mar; 49(11):2574-84. PubMed ID: 20141168
[TBL] [Abstract][Full Text] [Related]
38. Residue-Based Preorganization of BH3-Derived α/β-Peptides: Modulating Affinity, Selectivity and Proteolytic Susceptibility in α-Helix Mimics.
Peterson-Kaufman KJ; Haase HS; Boersma MD; Lee EF; Fairlie WD; Gellman SH
ACS Chem Biol; 2015 Jul; 10(7):1667-75. PubMed ID: 25946900
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for the interaction between DJ-1 and Bcl-X
Lee MK; Lee MS; Bae DW; Lee DH; Cha SS; Chi SW
Biochem Biophys Res Commun; 2018 Jan; 495(1):1067-1073. PubMed ID: 29175327
[TBL] [Abstract][Full Text] [Related]
40. Structural characterization of an intrinsically unfolded mini-HBX protein from hepatitis B virus.
Lee SH; Cha EJ; Lim JE; Kwon SH; Kim DH; Cho H; Han KH
Mol Cells; 2012 Aug; 34(2):165-9. PubMed ID: 22820921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
